ARCHIVES

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

This article is from The Cancer Letter archive.

Vol. 24 No. 27 | July 10, 1998

Download PDF Visit The Full Archive

Related Articles

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990

Funding Opportunities.

May 31, 2002